Adults with high levels of playfulness showed strong resilience during the COVID-19 pandemic compared to less playful individuals, new research shows.
FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer
The FDA approved nogapendekin alfa inbakicept (Anktiva) for bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC), the agency announced Monday. A first-in-class interleukin (IL)-15 receptor agonist,